RCRong Cai

Rong Cai

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rong Cai has a total of 136 co-authors. Here are the top co-authors by number of shared publications:

  • Chunying Chen

    CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety & CAS Center for Excellence in Nanoscience National Center for Nanoscience and Technology of China Beijing China

    15 shared publications
  • Mengyu Guo

    New Cornerstone Science Laboratory, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety & CAS Center for Excellence in Nanoscience

    5 shared publications
  • Mingdi Hu

    New Cornerstone Science Laboratory, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety & CAS Center for Excellence in Nanoscience

    4 shared publications
  • Yuliang Zhao

    Institute of Nanotechnology and Intelligence (inAI), and College of Chemistry and Materials Science, Jinan University, Guangzhou, China

    4 shared publications
  • Jingchao Li

    3 shared publications
  • Wenting Zhang

    New Cornerstone Science Laboratory, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety & CAS Center for Excellence in Nanoscience

    3 shared publications

Latest Publications

  • Adaptive Protein Corona Nanoassemblies Couple Cytokine Signaling with Endogenous Antigen Transport for Systemic Cancer Immunity

    by Susu Gao, Rui Luo, Chenxi Dai, Shuhan Zhang, Boya Liao, Ziwei Chen, Yuecong Guo, Mengyu Guo, Jingrui Zhang, Kai Zhang, et al.

    Protein corona formation is widely viewed as an inevitable but poorly controlled event when nanoparticles encounter biological environments. Converting this interfacial layer into a programmable functional entityremains a major challenge. Here, we report an adaptive protein corona nanoassembly strategy that integrates cytokine signaling with endogenous antigen transport. Coordination-engineered manganese nanoscaffolds were assembled with interleukin-12 (IL-12) and protected by an enzyme-responsive hyaluronic acid shell to form nanoshuttles (NSs) capable of dynamic protein recruitment in the tumor microenvironment (TME). Following enzymatic activation, exposure of the cationic manganese surface promotes adaptive corona formation and efficient capture of tumor-derived antigens. The resulting antigen-associated nanoassemblies traffic to tumor-draining lymph nodes, where they facilitate dendritic cell cross-presentation and tumor-specific T-cell priming. This coordinated process couples intratumoral cytokine signaling with antigen delivery, generating potent systemic antitumor immunity at significantly reduced IL-12 doses. These findings establish adaptive protein corona nanoassembly as a chemical strategy for programming nano–bio interfaces to coordinate cytokine signaling and antigen transport.

  • Chiral Polyproline Enables Functional Stealth for Simultaneous Long Circulation and Endoplasmic Reticulum-Targeted Antigen Presentation

    by Mingdi Hu, Yahui He, Liyuan Wu, Wen Su, Wenting Zhang, Xiaoman Yu, Mengyu Guo, Yutong Li, Hua Lu, Chunying Chen, et al.

    Stealth polymer modification is a cornerstone strategy to prolong nanomedicine circulation. However, traditional stealth polymers typically rely on hydration layers or flexible structures to achieve passive antifouling, which is accompanied by intrinsic functional inertness. Here, we report a "functional stealth" strategy using polyproline (PP), a natural amino acid polymer. By leveraging its intrinsic chirality and highly ordered polyproline II (PPII) helical structure, we actively regulate both the in vivo fate and intracellular trafficking of nanoparticles. We engineered gold nanoparticles (AuNPs) modified with l-polyproline (PLP) or d-polyproline (PDP) and demonstrated that L-type AuNPs exhibit superior stealth performance in the blood. Mechanistically, the L-type surface preferentially recruits dysopsonins while inhibiting opsonin adsorption, effectively evading rapid clearance by hepatic and splenic macrophages. Remarkably, the PPII helix of PLP allowed it to selectively "hijack" the endoplasmic reticulum (ER) resident chaperone HSP47, endowing the nanoparticles with intrinsic ER-targeting capability that was absent in conventional inert stealth materials. Leveraging this, we developed chiral nanovaccines by loading tumor antigen peptides onto chiral AuNPs. The L-type surface structure promotes vaccine accumulation within the ER, enhancing antigen entry into the MHC I presentation pathway. This significantly improves antigen presentation efficiency, elicits potent antigen-specific cellular immunity, and suppresses tumor growth. In conclusion, this study elucidates how surface chiral topology can program nanoparticle fate and immune function at the molecular level. PLP represents a paradigm of "functional stealth" polymers, showing that designing surface structures with specific biorecognition properties can simultaneously evade nonspecific clearance and activate targeted intracellular functions.


  • Open Access

    A comparative biodistribution and toxicity study of single and multi-component nanomaterials: NMs: TiO2, SiC, and SiC@TiO2

    by Wenting Zhang, Muhammad Daniyal Ghouri, Magda Blosi, Ying Liu, Chunying Chen, Flemming R. Cassee, Rong Cai

    With the increasing integration of nanomaterials (NMs) into daily life, their technological advantages have become evident. However, their intricate intera


  • Open Access

    mRNA compartmentalization via multimodule DNA nanostructure assembly augments the immunogenicity and efficacy of cancer mRNA vaccine

    by Xiaocui Guo, Mengyu Guo, Rong Cai, Mingdi Hu, Le Rao, Wen Su, He Liu, Fene Gao, Xiaoyu Zhang, Jing Liu, et al.

    Messenger RNA (mRNA) vaccine has fueled a great hope for cancer immunotherapy. However, low immunogenicity, caused by inefficient mRNA expression and weak immune stimulation, hampers the efficacy of mRNA vaccines. Here, we present an mRNA compartmentalization–based cancer vaccine, comprising a multimodule DNA nanostructure (MMDNS)–assembled compartment for efficient mRNA translation via in situ localizing mRNA concentration and relevant reaction molecules. The MMDNS is constructed via programmable DNA hybridization chain reaction (HCR)–based strategy, with integrating antigen-coded mRNA, CpG oligodeoxynucleotides (ODNs), acidic-responsive DNA sequence, and dendritic cells targeting aptamer. MMDNS undergoes in situ assembly in acidic lysosomes to form a micro-sized aggregate, inducing an enhanced CpG ODN adjuvant efficacy. Subsequently, the aggregates escape into cytoplasm, providing a moderate compartment which supports the efficient translation of spatially proximal mRNA transcripts via localizing relevant reaction molecules. The mRNA compartmentalization–based vaccine boosts a strong immune response and effectively inhibits tumor growth and metastasis, offering a robust strategy for cancer immunotherapy.


  • Open Access

    Protein corona potentiates the recovery of nanoparticle-induced disrupted tight junctions in endothelial cells

    by Muhammad Daniyal Ghouri, Ayesha Tariq, Jabran Saleem, Abdul Muhaymin, Rong Cai, Chunying Chen

    The protein corona facilitates the recovery of tight junctions disrupted by nanoparticles in endothelial cells and star shape-dependent protein corona induces the aggregates of cell junction proteins.


  • Chemical and biophysical characteristics of protein corona in nanomedicine and its regulatory strategies

    by Wenting Zhang, Mingdi Hu, Rong Cai, Chunying Chen

    Owing to the great potential of nanomaterials (NMs) to treat human diseases and mitigate the toxicity of engineered NMs, the research and development of NMs have geometrically increased. However, the development of technology to synthesize most nanomaterials is still in the early stage, and only a few NMs are approved and clinically used. There is a serious disconnect between industry and research mainly due to the limited understanding of the dynamic and variation in interactions between nanomaterials and biological microenvironments. NMs undergo multifaceted in vivo delivery processes after systemic administration, including circulation in the blood, distribution to tissues and organs, interactions with extracellular matrix components and cells, and intracellular trafficking and secretion. After the administration of NMs, proteins and other biomolecules are deposited on their surfaces via electrostatic, van der Waals, or hydrophobic forces and form protein corona (PC), which is the first in vivo biological barrier encountered by NMs. The formation of PC is a dynamic, competitive, and complex process that is affected by the physicochemical properties of NMs, characteristics of biological fluids, and environmental factors. PC modifies the physicochemical properties of NMs and endows them with new biological identities, which determine the course of various biological events, such as cellular uptake, immune response, biodistribution, clearance, and toxicity. The characterization of PC formation and its influence on NMs and proteins is the first step to thoroughly understanding complex nano-bio interactions. Accordingly, the characterization of PC includes the analysis of the formation process and mechanisms of PC; it also involves the analysis of the effects of PC on the properties of the NMs and proteins. The formation of PC is not conducive to the application of NMs in vivo. To overcome the adverse effects of PC, the design of active regulatory strategies, including the regulation of its content, composition, and structure, is garnering attention in the nanomedicine field. Thus, it is necessary to systematically establish the relationship among NMs, PCs, and biological effects, which will help in predicting and controlling the fate of in vivo nanomedicine, thereby assisting in designing safer and more effective nanomedicine. In this review, factors affecting the formation of PC, analytical methods, and biological effects of PC are thoroughly discussed. Additionally, new strategies to actively manipulate PC to assist in nanomedicine design are emphasized. Finally, we summarize the problems and challenges in PC studies and propose possible strategies.


  • Dual-modulation of immunosuppressive pathways using sono-activatable semiconducting polymer nanofeedbacks for cancer immunotherapy

    by Ningyue Yu, Meng Li, Yijing Zhang, Fengshuo Wang, Xiangrong Yu, Rong Cai, Jingchao Li


  • Open Access

    Engineered Nano–Bio Interfaces for Stem Cell Therapy

    by Arsalan Umer, Muhammad Daniyal Ghouri, Theoneste Muyizere, Raja Muhammad Aqib, Abdul Muhaymin, Rong Cai, Chunying Chen

    Engineered nanomaterials (ENMs) with different topographies provide effective nano-bio interfaces for controlling the differentiation of stem cells. The interaction of stem cells with nanoscale topographies and chemical cues in their microenvironment at the nano-bio interface can guide their fate. The use of nanotopographical cues, in particular nanorods, nanopillars, nanogrooves, nanofibers, and nanopits, as well as biochemical forces mediated factors, including growth factors, cytokines, and extracellular matrix proteins, can significantly impact stem cell differentiation. These factors were seen as very effective in determining the proliferation and spreading of stem cells. The specific outgrowth of stem cells can be decided with size variation of topographic nanomaterial along with variation in matrix stiffness and surface structure like a special arrangement. The precision chemistry enabled controlled design, synthesis, and chemical composition of ENMs can regulate stem cell behaviors. The parameters of size such as aspect ratio, diameter, and pore size of nanotopographic structures are the main factors for specific termination of stem cells. Protein corona nanoparticles (NPs) have shown a powerful facet in stem cell therapy, where combining specific proteins could facilitate a certain stem cell differentiation and cellular proliferation. Nano-bio reactions implicate the interaction between biological entities and nanoparticles, which can be used to tailor the stem cells' culmination. The ion release can also be a parameter to enhance cellular proliferation and to commit the early differentiation of stem cells. Further research is needed to fully understand the mechanisms underlying the interactions between engineered nano-bio interfaces and stem cells and to develop optimized regenerative medicine and tissue engineering designs.


  • Optimal delivery strategies for nanoparticle-mediated mRNA delivery

    by Xiaoyan Li, Xiaocui Guo, Mingdi Hu, Rong Cai, Chunying Chen

    The nanoparticle-bio interaction occurs at overall stages during thein vivojourney of nanoparticle-mRNA formulations. Optimal delivery strategies based nano-bio interaction is dedicated for an ideal mRNA delivery system.


  • Inhibitor-Decorated Nanoscale Semiconducting Polymer Prodrugs for Photodynamically Amplified Chemotherapy and Metastasis Inhibition

    by Danling Cheng, Jiacheng He, Chuanhong Zhang, Yijing Zhang, Ningyue Yu, Rong Cai, Xiuhui Wang, Jingchao Li